Literature DB >> 10716076

Tuberculous meningitis in children: clinical features and outcome in 40 cases.

H Paganini1, F Gonzalez, C Santander, L Casimir, G Berberian, M T Rosanova.   

Abstract

In order to assess the epidemiology, clinical features and outcome of tuberculous meningitis, a retrospective review of patients was conducted between January 1989 and December 1995. Forty cases (representing 10%, of all paediatric patients with tuberculosis) were included. Mean age was 46 months (range 1-165 months). Eighteen (45%) children were classified as stage I (non-specific febrile illness without neurological signs), 16 (40%) as stage II (neurological signs without marked changes in sensorium) and 6 (15%) as stage III (major neurological signs with sensorial changes and/or coma). Twenty-seven (67%) patients had received BCG vaccination and 14 (35%) displayed an induration zone higher than 10 mm after a 2-TU PPD test. Mycobacterium tuberculosis was recovered from 24 (61%) patients. Hydrocephalus was demonstrated by cranial computed tomography in 31 (78%) children. Overall, 18 (45%) children had a full recovery. Mild, moderate and severe neurological sequelae were shown by 7 (18%), 3 (8%) and 9 (22%) of the patients, respectively. Three fatal cases (7%) were observed. The presence of seizures (RR 15.6, 2.02-119.1) and absence of extrameningeal foci (RR 4.95, 1.10-22.1) were identified as risk factors by multivariate analysis. These findings emphasize the need quickly to diagnose tuberculosis in children in order to give appropriate and early treatment.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10716076     DOI: 10.1080/00365540050164209

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  6 in total

Review 1.  Non-traumatic coma in children.

Authors:  F J Kirkham
Journal:  Arch Dis Child       Date:  2001-10       Impact factor: 3.791

2.  Presentation and outcome of tuberculous meningitis among children: experiences from a tertiary children's hospital.

Authors:  Nicolette Nabukeera-Barungi; Jo Wilmshurst; Muloiwa Rudzani; James Nuttall
Journal:  Afr Health Sci       Date:  2014-03       Impact factor: 0.927

3.  Tuberculous meningitis and HIV.

Authors:  Sunil Karande; Vishal Gupta; Madhuri Kulkarni; Anagha Joshi; Mhisti Rele
Journal:  Indian J Pediatr       Date:  2005-09       Impact factor: 1.967

4.  BCG vaccination in patients with severe combined immunodeficiency: complications, risks, and vaccination policies.

Authors:  Beatriz E Marciano; Chiung-Yu Huang; Gyan Joshi; Nima Rezaei; Beatriz Costa Carvalho; Zoe Allwood; Aydan Ikinciogullari; Shereen M Reda; Andrew Gennery; Vojtech Thon; Francisco Espinosa-Rosales; Waleed Al-Herz; Oscar Porras; Anna Shcherbina; Anna Szaflarska; Şebnem Kiliç; Jose L Franco; Andrea C Gómez Raccio; Persio Roxo; Isabel Esteves; Nermeen Galal; Anete Sevciovic Grumach; Salem Al-Tamemi; Alisan Yildiran; Julio C Orellana; Masafumi Yamada; Tomohiro Morio; Diana Liberatore; Yoshitoshi Ohtsuka; Yu-Lung Lau; Ryuta Nishikomori; Carlos Torres-Lozano; Juliana T L Mazzucchelli; Maria M S Vilela; Fabiola S Tavares; Luciana Cunha; Jorge A Pinto; Sara E Espinosa-Padilla; Leticia Hernandez-Nieto; Reem A Elfeky; Tadashi Ariga; Heike Toshio; Figen Dogu; Funda Cipe; Renata Formankova; M Enriqueta Nuñez-Nuñez; Liliana Bezrodnik; Jose Gonçalo Marques; María I Pereira; Viviana Listello; Mary A Slatter; Zohreh Nademi; Danuta Kowalczyk; Thomas A Fleisher; Graham Davies; Bénédicte Neven; Sergio D Rosenzweig
Journal:  J Allergy Clin Immunol       Date:  2014-04       Impact factor: 10.793

5.  Use of IMiD3, a thalidomide analog, as an adjunct to therapy for experimental tuberculous meningitis.

Authors:  Liana Tsenova; Bande Mangaliso; George Muller; Yong Chen; Victoria H Freedman; David Stirling; Gilla Kaplan
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

6.  Clinical presentations, diagnosis, mortality and prognostic markers of tuberculous meningitis in Vietnamese children: a prospective descriptive study.

Authors:  Nguyen Duc Bang; Maxine Caws; Thai Thanh Truc; Tran Ngoc Duong; Nguyen Huy Dung; Dang Thi Minh Ha; Guy E Thwaites; Doortje Heemskerk; Joel Tarning; Laura Merson; Pham Van Toi; Jeremy J Farrar; Marcel Wolbers; Thomas Pouplin; Jeremy N Day
Journal:  BMC Infect Dis       Date:  2016-10-18       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.